Drug research

Descartes-08

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Descartes-08 in Autoantibody MyositisNCT07391605	Cartesian Therapeutics	Phase 2	Recruiting	2027-11Estimated
Descartes-08 for Patients With Systemic Lupus ErythematosusNCT06038474	Cartesian Therapeutics	Phase 2	Active not recruiting	2026-12-01Estimated
Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)NCT04146051	Cartesian Therapeutics	Phase 2	Active not recruiting	2026-01-05Actual

Cartesian TherapeuticsRecruitingPrimary completion: 2027-11 · Estimated

Trial details

Cartesian TherapeuticsActive not recruitingPrimary completion: 2026-12-01 · Estimated

Trial details

Cartesian TherapeuticsActive not recruitingPrimary completion: 2026-01-05 · Actual

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.